Routine primary prophylaxis for febrile neutropenia with biosimilar granulocyte colony-stimulating factor (nivestim) or pegfilgrastim is cost effective in non-Hodgkin lymphoma patients undergoing curative-intent R-CHOP chemotherapy

Routine primary prophylaxis for febrile neutropenia with biosimilar granulocyte colony-stimulating factor (nivestim) or pegfilgrastim is cost effective in non-Hodgkin lymphoma patients undergoing curative-intent R-CHOP chemotherapy

10.1371/journal.pone.0148901

Saved in:
Bibliographic Details
Main Authors: Wang X.J., Tang T., Farid M., Quek R., Tao M., Lim S.T., Wee H.L., Chan A.
Other Authors: PHARMACY
Format: Article
Published: Public Library of Science (PLoS) 2018
Online Access:http://scholarbank.nus.edu.sg/handle/10635/142662
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1371/journal.pone.0148901

Similar Items